Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies

Webb, Richard and Al-Asmakh, Maha and Banach, Maciej and Mazidi, Mohsen (2024) Application of proteomics for novel drug discovery and risk prediction optimisation in stroke and myocardial infarction: a review of in-human studies. Drug Discovery Today, 29 (11). ISSN 1359-6446

Text Proteomics CVD Review Paper (v1.15).docx - Accepted Version Restricted to Repository staff only until 27 September 2025. Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (280kB) | Request a copy

Abstract

The use of proteomics in human studies investigating stroke and myocardial infarction (MI) has been increasing, prompting a review of the literature. This revealed proteinaceous biomarkers of stroke from thrombi, brain tissue, cells, and particles, some of which cross the blood–brain barrier (BBB). Several proteins were also implicated in coronary artery disease (CAD), which often underlies MI, cholesterol transportation, and inflammation. Furthermore, the platelet proteome revealed itself as a potential therapeutic target, along with differentially expressed proteins associated with MI progression. Moreover, proteomic data enhanced the performance of conventional risk scores and causal protein discovery has improved interventions and drug development for patients with MI and other conditions. These findings suggest that proteomics holds much promise for future stroke and MI research.

Item Type:	Article
Faculty / Department:	Faculty of Human and Digital Sciences > School of Health and Sport Sciences
Depositing User:	Richard Webb
Date Deposited:	14 Oct 2024 10:33
Last Modified:	14 Oct 2024 10:33
URI:	https://hira.hope.ac.uk/id/eprint/4376

Actions (login required)

View Item